Fundamentals of Aerosol Delivery

Aerosol therapy delivers medication directly to the airways using devices that generate particles small enough to reach target sites and the effectiveness of delivery depends on particle size inspiratory flow pattern device performance and patient technique. Devices include metered dose inhalers with or without spacers dry powder inhalers and nebulizers and each has advantages and limitations in different clinical contexts. Particle size distribution influences deposition with larger particles depositing in central airways and smaller particles reaching peripheral airways and alveoli. Patient factors such as inspiratory capacity coordination and airway obstruction alter deposition and clinicians tailor device selection and instruction to the individual. Education on inhaler technique and on device maintenance is essential to achieve therapeutic goals and to reduce waste and adverse effects.

Device Selection and Optimization

Selecting the right device considers the medication formulation patient ability and clinical setting and spacers improve delivery from metered dose inhalers by reducing oropharyngeal deposition and by simplifying coordination. Dry powder inhalers require adequate inspiratory flow and are unsuitable for patients with severe airflow limitation who cannot generate sufficient flow. Jet nebulizers are versatile and can be used with oxygen and with ventilator circuits while vibrating mesh nebulizers provide efficient delivery with lower residual volume and shorter treatment times. Optimizing delivery includes using appropriate particle generating settings ensuring correct device assembly and instructing patients on breath hold and on slow deep inhalation when indicated. Regular review of technique and of device condition prevents suboptimal therapy.

Safety Infection Control and Monitoring

Aerosol therapy carries infection control considerations especially in contagious respiratory disease and single patient use devices and appropriate cleaning and disinfection protocols reduce cross contamination risk. When delivering aerosols to patients on ventilators in critical care closed circuit nebulization and in line vibrating mesh devices reduce environmental contamination. Monitoring therapy effectiveness includes assessing symptom relief lung function and side effects such as tachycardia or tremor for beta agonists and local irritation for inhaled corticosteroids. Documentation of device type dose and patient response supports continuity of care and helps identify adherence issues that may require alternative strategies.